Channing Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-36,974
| Closed | -$7.17M | – | 110 |
|
|
2024
Q3 | $7.17M | Sell |
36,974
-691
| -2% | -$134K | 0.18% | 96 |
|
|
2024
Q2 | $8.73M | Sell |
37,665
-738
| -2% | -$171K | 0.24% | 75 |
|
|
2024
Q1 | $8.28M | Buy |
38,403
+4,300
| +13% | +$927K | 0.22% | 81 |
|
|
2023
Q4 | $8.82M | Buy |
34,103
+4,077
| +14% | +$1.06M | 0.26% | 66 |
|
|
2023
Q3 | $7.72M | Buy |
+30,026
| New | +$7.72M | 0.25% | 71 |
|
|
2018
Q3 | – | Sell |
-26,500
| Closed | -$7.69M | – | 104 |
|
|
2018
Q2 | $7.69M | Sell |
26,500
-3,729
| -12% | -$1.08M | 0.27% | 77 |
|
|
2018
Q1 | $8.28M | Buy |
30,229
+4,468
| +17% | +$1.22M | 0.29% | 74 |
|
|
2017
Q4 | $8.21M | Buy |
25,761
+1
| +0% | +$319 | 0.28% | 77 |
|
|
2017
Q3 | $8.07M | Sell |
25,760
-897
| -3% | -$281K | 0.3% | 78 |
|
|
2017
Q2 | $7.23M | Buy |
26,657
+1,909
| +8% | +$518K | 0.28% | 79 |
|
|
2017
Q1 | $6.77M | Buy |
24,748
+1,725
| +7% | +$472K | 0.25% | 84 |
|
|
2016
Q4 | $6.53M | Sell |
23,023
-7,113
| -24% | -$2.02M | 0.23% | 85 |
|
|
2016
Q3 | $9.43M | Hold |
30,136
| – | – | 0.38% | 66 |
|
|
2016
Q2 | $7.29M | Buy |
30,136
+6,883
| +30% | +$1.66M | 0.31% | 81 |
|
|
2016
Q1 | $6.05M | Buy |
+23,253
| New | +$6.05M | 0.27% | 79 |
|